Home NDC 50845-0227-2 Acne
Product NDC 50845-0227
Requested package NDC 50845-0227-2
11-digit product format 508450227
Labeler code 50845
Product ID 50845-0227_514d929c-f3dc-482c-bc3e-1cee8d180e8b
Type HUMAN OTC DRUG
Nonproprietary name Anthracinum, Antimonium Crudum, Hydrocotyle Asiatica, Juglans Regia, Kali Bromatum, Ledum Palustre, Natrum Sulphuricum, Pyrogenium, Radium Bromatum, Sanguinaria Canadensis, Sulphur Iodatum, Thuja Occidentalis, Urtica Urens
Dosage form SPRAY
Route ORAL
Labeler Liddell Laboratories, Inc.
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 2016-05-02
Marketing end 2022-07-05
Substance ANTIMONY TRISULFIDE; BACILLUS ANTHRACIS IMMUNOSERUM RABBIT; CENTELLA ASIATICA; JUGLANS REGIA FLOWERING TOP; POTASSIUM BROMIDE; RADIUM BROMIDE; RANCID BEEF; RHODODENDRON TOMENTOSUM LEAFY TWIG; SANGUINARIA CANADENSIS ROOT; SODIUM SULFATE; SULFUR IODIDE; THUJA OCCIDENTALIS LEAFY TWIG; URTICA URENS WHOLE
Active strength 30 [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 15 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Code, Status table Captured / source date Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2022-04-09 23:13 UTC · source 2022-04-08 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 I Inactivated by FDA bd6a592717d7…303034d00443…2020-06-10 20:45 UTC · source 2020-06-10 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 50845-0227-2 50845022702 1 BOTTLE, SPRAY in 1 CARTON (50845-0227-2) > 30 mL in 1 BOTTLE, SPRAY (50845-0227-1) 2016-05-02 2022-07-05 No No Current